Terns Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:TERN) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

뉴스

Viatris Stock to Report Q4 Earnings: What's in the Cards?

Leerink Partners avvia copertura su Terns Pharmaceuticals con rating Outperform

Leerink Partners initiates Terns Pharmaceuticals stock with Outperform rating

Wall Street Analysts See a 50.91% Upside in Terns Pharmaceuticals (TERN): Can the Stock Really Move This High?

I migliori titoli biotech da tenere d’occhio nel 2026, secondo Truist

Top Biotech Stocks to Watch in 2026, According to Truist

HBM Healthcare: utile di 9 mesi raggiunge 286 milioni di CHF con NAV in crescita del 18%

Swiss HBM Healthcare nine-month profit hits CHF 286 mln as NAV jumps 18%

Lyssikatos, CSO di Enliven Therapeutics, vende azioni ELVN per 535.000$

Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock

Terns Pharmaceuticals modifica l’accordo di licenza con Hansoh per i diritti di TERN-701

Terns Pharmaceuticals amends license agreement with Hansoh for TERN-701 rights